Zions President McLean exercises and sells shares

Zions Bancorporation, National Association reported insider transactions by President & COO Scott J. McLean on February 2, 2026.

Rhea-AI Filing Summary

Zions Bancorporation, National Association reported insider transactions by President & COO Scott J. McLean on February 2, 2026. McLean exercised multiple stock options for 1,955 and 11,665 shares at $51.17, and 2,190 and 17,315 shares at $45.65.

He then sold 11,665 shares at a weighted average price of $61.143 and 17,315 shares at $61.147, both executed in multiple trades within narrow price ranges. After these exercises and sales, McLean directly owned 84,440 shares of Zions common stock.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 10 txns

Insider MCLEAN SCOTT J

Role President

Sold 28,980 shs ($1.77M)

Approx. gross sale proceeds $1.77M

Approx. exercise cost $1.59M

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	1,955	$51.17	$100K
Exercise	Stock Option (right to buy)	11,665	$51.17	$597K
Exercise	Stock Option (right to buy)	2,190	$45.65	$100K
Exercise	Stock Option (right to buy)	17,315	$45.65	$790K
Exercise	Common Stock	1,955	$51.17	$100K
Exercise	Common Stock	11,665	$51.17	$597K
Sale	Common Stock	11,665	$61.143	$713K
Exercise	Common Stock	2,190	$45.65	$100K
Exercise	Common Stock	17,315	$45.65	$790K
Sale	Common Stock	17,315	$61.147	$1.06M

Holdings After Transaction: Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 84,440 shares (Direct)

Footnotes (3)

1. F1. This transaction was executed in multiple trades at prices ranging from $61.12 to $61.20. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
2. F2. This transaction was executed in multiple trades at prices ranging from $61.13 to $61.19. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
3. F3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did ZION President Scott McLean report on February 2, 2026?

Scott McLean reported exercising several stock options and selling shares on February 2, 2026. He exercised options for 1,955, 11,665, 2,190, and 17,315 Zions common shares, then sold 11,665 and 17,315 shares at weighted average prices around $61 per share.

How many ZION shares does Scott McLean own after the reported Form 4 transactions?

After the reported transactions, Scott McLean directly owns 84,440 shares of Zions common stock. This figure reflects the net position following multiple stock option exercises and two sales of 11,665 and 17,315 shares on February 2, 2026, as disclosed in the filing.

At what prices did Scott McLean exercise and sell his Zions (ZION) shares?

Scott McLean exercised stock options at $51.17 and $45.65 per share and sold shares at weighted average prices of $61.143 and $61.147. The sales occurred through multiple trades within narrow ranges of $61.12–$61.20 and $61.13–$61.19, respectively.

What types of securities are covered in Scott McLean’s ZION Form 4 filing?

The filing covers both derivative and non-derivative Zions securities. It reports exercises of stock options (rights to buy common stock) at strike prices of $51.17 and $45.65, and subsequent transactions in the underlying Zions common stock, including purchases via exercises and open-market sales.

What role does Scott McLean hold at Zions Bancorporation (ZION) in this Form 4?

Scott McLean is identified as an officer of Zions Bancorporation, serving as President and COO. The Form 4 is filed for one reporting person, reflecting his direct ownership and transactions in Zions common stock and related stock options on February 2, 2026.

How were the ZION share sale prices calculated in Scott McLean’s Form 4?

The reported sale prices of $61.143 and $61.147 are weighted average prices. Each sale transaction was executed in multiple trades within specified price ranges, and the filing states that full trade details are available upon request to the SEC staff, issuer, or security holders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCLEAN SCOTT J

(Last) (First) (Middle)

ONE SOUTH MAIN STREET, 11TH FLOOR

SALT LAKE CITY

(Street)

UT 84133-1109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ [ ZION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)	X	Other (specify below)
	President		& COO

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		M		1,955	A	$51.17	82,250	D
Common Stock	02/02/2026		M		11,665	A	$51.17	93,915	D
Common Stock	02/02/2026		S		11,665	D	$61.143(1)	82,250	D
Common Stock	02/02/2026		M		2,190	A	$45.65	84,440	D
Common Stock	02/02/2026		M		17,315	A	$45.65	101,755	D
Common Stock	02/02/2026		S		17,315	D	$61.147(2)	84,440	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$51.17	02/02/2026		M			1,955	(3)	02/28/2026	Common Stock	1,955	$51.17	11,665	D
Stock Option (right to buy)	$51.17	02/02/2026		M			11,665	(3)	02/28/2026	Common Stock	11,665	$51.17	0	D
Stock Option (right to buy)	$45.65	02/02/2026		M			2,190	(3)	02/09/2027	Common Stock	2,190	$45.65	17,315	D
Stock Option (right to buy)	$45.65	02/02/2026		M			17,315	(3)	02/09/2027	Common Stock	17,315	$45.65	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $61.12 to $61.20. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

2. This transaction was executed in multiple trades at prices ranging from $61.13 to $61.19. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

Remarks:

	By Rena Miller as attorney in fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.